Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2

被引:23
作者
Agamennone, M
Campestre, C
Preziuso, S
Consalvi, V
Crucianelli, M
Mazza, F
Politi, V
Ragno, R
Tortorella, P
Gallina, C
机构
[1] Univ G dAnnunzio, Dipartimento Sci Farmaco, I-66013 Chieti, Italy
[2] Univ Roma La Sapienza, Dipartimento Sci Biochim, I-00185 Rome, Italy
[3] Univ Aquila, Dipartimento Chim Ingn Chim & Mat, I-67010 Coppito, Italy
[4] Polifarma Res Ctr, I-00185 Rome, Italy
[5] Univ Bari, Dipartimento Farmacochim, I-70125 Bari, Italy
关键词
MMP; matrix metalloproteinases inhibitors; tripeptide phosphonates; right-hand inhibitors; left-hand inhibitors;
D O I
10.1016/j.ejmech.2004.10.013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The phosphotryptophan derivative L-Pro-L-LeU-L-(P)Trp(OH)(2) (2b) was reported as the first example of left-hand-side(1) phosphonate inhibitor of MMP-8. Its uncommon mode of binding to MMP-8 was mainly ascribed to the presence of the proline residue in P, Ten new analogues of 2b were obtained by replacement of the aminoterminal L-Pro with aminoacid residues bearing small side chains. Most of the new analogues show an increase of affinity for MMP-2 and MMP-8, and different profiles of selectivity. Computer simulations were performed to explain the effects of substitutions on the preferred mode of binding. They reveal that most of the new analogues are probably accommodated in the right. rather than left-hand side of MMP-8 active site. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:271 / 279
页数:9
相关论文
共 34 条
[1]   Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis [J].
Ahrens, D ;
Koch, AE ;
Pope, RM ;
SteinPicarella, M ;
Niedbala, MJ .
ARTHRITIS AND RHEUMATISM, 1996, 39 (09) :1576-1587
[2]   Computational study of the catalytic domain of human neutrophil collagenase.: Specific role of the S3 and S′3 subsites in the interaction with a phosphonate inhibitor [J].
Aschi, M ;
Roccatano, D ;
Di Nola, A ;
Gallina, C ;
Gavuzzo, E ;
Pochetti, G ;
Pieper, M ;
Tschesche, H ;
Mazza, F .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (03) :213-225
[3]   Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[4]   Metalloproteinase inhibitors: biological actions and therapeutic opportunities [J].
Baker, AH ;
Edwards, DR ;
Murphy, G .
JOURNAL OF CELL SCIENCE, 2002, 115 (19) :3719-3727
[5]  
BLASS JP, 1996, ALZHEIMERS DIS REV, V1, P17
[6]   Matrix metalloproteinases degrade myelin basic protein [J].
Chandler, S ;
Coates, R ;
Gearing, A ;
Lury, J ;
Wells, G ;
Bone, E .
NEUROSCIENCE LETTERS, 1995, 201 (03) :223-226
[7]   2 angstrom X-ray structure of adamalysin II complexed with a peptide phosphonate inhibitor adopting a retro-binding mode [J].
Cirilli, M ;
Gallina, C ;
Gavuzzo, E ;
Giordano, C ;
GomisRuth, FX ;
Gorini, B ;
Kress, LF ;
Mazza, F ;
Paradisi, MP ;
Pochetti, G ;
Politi, V .
FEBS LETTERS, 1997, 418 (03) :319-322
[8]   Inhibition of adamalysin II and MMPs by phosphonate analogues of snake venom peptides [J].
D'Alessio, S ;
Gallina, C ;
Gavuzzo, E ;
Giordano, C ;
Gorini, B ;
Mazza, F ;
Paradisi, MP ;
Panini, G ;
Pochetti, G ;
Sella, A .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (02) :389-394
[9]  
FOLKMAN J, 1992, J BIOL CHEM, V267, P10931
[10]   Synthesis and identification of conformationally constrained selective MMP inhibitors [J].
Freskos, JN ;
McDonald, JJ ;
Mischke, BV ;
Mullins, PB ;
Shieh, HS ;
Stegeman, RA ;
Stevens, AM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (13) :1757-1760